Sirolimus
Products in Health Canada’s databases that list Sirolimus as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 8
- 4 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 20
- Products in all
- 8
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| RAPAMUNE (1 MG) | 02243237 | Marketed | Pfizer Canada Ulc | |
| RAPAMUNE (1 MG) | 02247111 | Marketed | Pfizer Canada Ulc | |
| GD-SIROLIMUS (1 MG) | 02373386 | Approved | Genmed A Division Of Pfizer Canada Ulc | |
| GD-SIROLIMUS (1 MG) | 02373394 | Approved | Genmed A Division Of Pfizer Canada Ulc | |
| GD-SIROLIMUS (2 MG) | 02373408 | Cancelled Pre Market | Genmed A Division Of Pfizer Canada Ulc | |
| GD-SIROLIMUS (5 MG) | 02373416 | Cancelled Pre Market | Genmed A Division Of Pfizer Canada Ulc | |
| RAPAMUNE (2 MG) | 02270617 | Cancelled Pre Market | Pfizer Canada Ulc | |
| RAPAMUNE (5 MG) | 02270684 | Cancelled Pre Market | Pfizer Canada Ulc |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- RAPAMUNEJuly 30, 2026 · NOC 38023
- RAPAMUNEJuly 25, 2025 · NOC 35741
- RAPAMUNEApril 4, 2024 · NOC 33000
- GD-SIROLIMUSMay 11, 2023 · NOC 30704
- RAPAMUNESeptember 13, 2022 · NOC 28955
- GD-SIROLIMUSApril 8, 2021 · NOC 25608
- RAPAMUNENovember 1, 2019 · NOC 22850
- RAPAMUNEOctober 30, 2018 · NOC 21476
- RAPAMUNEJuly 22, 2015 · NOC 17192
- GD-SIROLIMUSOctober 4, 2011 · NOC 12679
- RAPAMUNEOctober 8, 2010 · NOC 11800
- RAPAMUNENovember 29, 2007 · NOC 9212
- RAPAMUNEMarch 23, 2007 · NOC 8665
- RAPAMUNEAugust 25, 2006 · NOC 8225
- RAPAMUNEAugust 29, 2005 · NOC 7333
- RAPAMUNEAugust 29, 2005 · NOC 7334
- RAPAMUNEMay 28, 2004 · NOC 3081
- RAPAMUNEMarch 10, 2003 · NOC 3580
- RAPAMUNEFebruary 10, 2003 · NOC 3585
- RAPAMUNEJanuary 5, 2001 · NOC 2597